BCAR3

gene product
NSP2, SH2D3B
Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
32 antibodies from 13 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
Bethyl Laboratories, Inc.
1 antibody
Abnova Corporation
3 antibodies
Novus Biologicals
10 antibodies
Atlas Antibodies
1 antibody
Acris Antibodies GmbH
1 antibody
GeneTex
2 antibodies
Creative Biomart
6 antibodies
Aviva Systems Biology
1 antibody
Thermo Fisher Scientific Pierce
2 antibodies
ProSci
1 antibody
Everest Biotech
1 antibody
LifeSpan BioSciences, Inc.
1 antibody
Sigma-Aldrich
2 antibodies